Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01349244 · ClinicalTrials.gov registry record
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
A clinical trial of Renal Colic and Hydronephrosis, sponsored by Yale University.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT01349244: Completed study of Renal Colic and Hydronephrosis, sponsored by Yale University.
NCT01349244 is a study of Renal Colic and Hydronephrosis that has completed, run by Yale University. The registered enrollment target is 97 participants, above the 67-participant average among 3 other Renal Colic trials with a reported enrollment target (45% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01349244, a study of Renal Colic and Hydronephrosis, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the overall sensitivity and specificity of hydronephrosis on point-of-care bedside ultrasound to identify hydronephrosis as compared to hydronephrosis found by CT.
Primary Outcome
To determine the overall sensitivity and specificity of hydronephrosis on point-of-care bedside ultrasound to identify hydronephrosis as compared to hydronephrosis found on by CT.
Conditions Studied
Study Locations (1)
Connecticut
- Yale University, Emergency Department - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-09 |
What the finished NCT01349244 record still lists
NCT01349244 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target, above the 67-participant average among 3 other Renal Colic trials with a reported enrollment target (45% higher).
The record links to 2 conditions, with Renal Colic appearing as the primary indexed condition, and to 0 interventions.
NCT01349244 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01349244 about?
NCT01349244 is a clinical study titled "Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic". The purpose of this study is to determine the overall sensitivity and specificity of hydronephrosis on point-of-care bedside ultrasound to identify hydronephrosis as compared to hydronephrosis found by CT.
What is the current status of trial NCT01349244?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2010-09. Estimated completion is 2012-09.
What conditions does trial NCT01349244 study?
This clinical trial studies the following conditions: Renal Colic, Hydronephrosis.
Who is sponsoring clinical trial NCT01349244?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01349244 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Colic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of AR / VR in Patients Presenting to the ED With Renal Colic
RECRUITING · NA
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Erector Spinae Plane (ESP) Block for Renal Colic
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia